Biotech company Sirtex Medical is facing two class actions over allegations it engaged in misleading and deceptive conduct in relation to missed sales forecasts for 2016-17, which sparked a share price plunge.
Biotech company Sirtex Medical is facing two class actions over allegations it engaged in misleading and deceptive conduct in relation to missed sales forecasts for 2016-17, which sparked a share price plunge.